RCM
TVGN icon

Radcliffe Capital Management’s Tevogen Inc. Common Stock TVGN Stock Holding History

Radcliffe Capital Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,493
Closed -$13.2M – 712
2022
Q4 		$13.2M Buy
25,493
+10,017
+65% +$5.13M 0.42% 24
2022
Q3 		$7.85M Buy
15,476
+430
+3% +$217K 0.19% 105
2022
Q2 		$7.53M Buy
15,046
+2,132
+17% +$1.07M 0.17% 109
2022
Q1 		$6.45M Buy
+12,914
New +$6.42M 0.15% 138

Other funds holding TVGN

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Radcliffe Capital Management's TVGN Position: Q1 2023 in Review

Radcliffe Capital Management sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 25,493 shares — an estimated $13.2M sold.

Radcliffe Capital Management first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $13.2M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

  • Radcliffe Capital Management reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 25,493 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $13.2M.
  • Radcliffe Capital Management first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Radcliffe Capital Management's Tevogen Inc. Common Stock position peaked at $13.2M in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.